ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma

Moertel, C. L., Hirbe, A. C., Shuhaiber, H. H., Bielamowicz, K., Sidhu, A., Viskochil, D., Weber, M. D., Lokku, A., Smith, L. M., Foreman, N. K., Hajjar, F. M., McNall-Knapp, R. Y., Weintraub, L., Antony, R., Franson, A. T., Meade, J., Schiff, D., Walbert, T., Ambady, P., … Sadighi, Z. (2024). ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.01034
Authors:
Christopher L Moertel
Angela C Hirbe
Hans H Shuhaiber
Kevin Bielamowicz
Alpa Sidhu
David Viskochil
Michael D Weber
Armend Lokku
L Mary Smith
Nicholas K Foreman
Fouad M Hajjar
Rene Y McNall-Knapp
Lauren Weintraub
Reuben Antony
Andrea T Franson
Julia Meade
David Schiff
Tobias Walbert
Prakash Ambady
Daniela A Bota
Cynthia J Campen
Gurcharanjeet Kaur
Laura J Klesse
Stefania Maraka
Paul L Moots
Kathryn Nevel
Miriam Bornhorst
Ana Aguilar-Bonilla
Sarah Chagnon
Nagma Dalvi
Punita Gupta
Ziad Khatib
Laura K Metrock
P Leia Nghiemphu
Ryan D Roberts
Nathan J Robison
Zsila Sadighi
Stacie Stapleton
Dusica Babovic-Vuksanovic
Timothy R Gershon
Affiliated Authors:
Gurcharanjeet Kaur
Publication Type:
Article
Unique ID:
10.1200/jco.24.01034
PMID:
Publication Date:
Data Source:
PubMed

Record Created: